Health Catalyst, Inc. (HCAT)
Health Catalyst, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Health Catalyst, Inc. (HCAT) is a Medical - Healthcare Information Services company based in US with a market capitalization of $104.6M. Revenue grew 1.5% year-over-year and free cash flow was negative at -$237K. This page tracks HCAT's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 1.5K employees · IPO Jul 25, 2019
Valuation
Valuation & price
$1.19 · as of May 17, 2026 · -70.9% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.43
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$104.6M
Market cap
1.5%
Revenue growth (YoY)
33.5%
Gross margin
-$237K
Free cash flow (USD)
$75.5M
Net debt
16.1%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2017 → 2025
Free cash flow by year
2017 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 11, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventUnit Purchase AgreementJun 4, 2026Filing
- 8-K eventEarnings ReleaseMay 11, 2026Filing
- Quarterly report10-Q FiledMay 11, 2026Filing
- 8-K eventDirector AppointmentApr 30, 2026Filing
- Annual report10-K FiledApr 30, 2026Filing
- 8-K eventWorkforce ReductionApr 27, 2026Filing
- 8-K eventCEO ResignationApr 3, 2026Filing
Questions
Frequently asked questions
What is Health Catalyst, Inc.'s market cap?
Health Catalyst, Inc. (HCAT) has a market capitalization of $104.6M.
What is HCAT's P/E ratio?
A meaningful P/E ratio is not available for HCAT — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is HCAT's price-to-book (P/B) ratio?
HCAT trades at 0.43 times book value per share.
Are insiders buying HCAT stock?
SEC Form 4 filings show no open-market insider buys at Health Catalyst, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Medical - Healthcare Information Services
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.